Overview

Gender

female

Dr. Curran brings over fifteen years of industry and research leadership in the commercialization of biotech crops and industrial microbes. Dr. Curran joins ZeaKal through the acquisition of Algenetix where she was the Chief Technology Officer and managed the company’s high oil biomass, yeast and algae programs.

Prior to Algenetix, Dr. Curran was with Rincon Pharmaceuticals, where she developed high throughput strategies to generate transgenic algal lines expressing therapeutic proteins. When Sapphire Energy acquired Rincon, Dr. Curran headed up research programs in developing transformation systems for novel industrial algal strains focused on the production of commercial bio-oils.

Dr. Curran graduated summa cum laude from San Diego State University with a degree in biology and has a Ph.D. in plant molecular biology from the University of California, San Diego. She has completed three postdocs at The Scripps Research Institute, The University of Western Australia and The University of Nevada, Reno.